Glycotest
About us
Management Team and Board
Scientific and Medical Advisors
Glycotest Investor Presentation
Investors
Technology
Clinical Data
Intellectual Property
News
Contact us
Glycotest
About us
Management Team and Board
Scientific and Medical Advisors
Glycotest Investor Presentation
Investors
Technology
Clinical Data
Intellectual Property
News
Contact us
NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune
October 3, 2014
-
News
-
No comments
-
Posted by
glycotest
← PREVIOUS POST
NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.
Leave a Comment
Your feedback is valuable for us. Your email will not be published.
Cancel Reply
Save my name, email, and website in this browser for the next time I comment.
Please wait...
Submit Comment
Related News
Other posts that you should not miss.
Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico.
March 1, 2023
-
News
Read More →
Posted by
glycotest
1 MIN READ
Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent.
January 13, 2021
-
News
Read More →
Posted by
glycotest
1 MIN READ
More than 50 Glycotest Fucosylated Biomarkers Protected through Grant of New US Patent.
November 3, 2020
-
News
Read More →
Posted by
glycotest
1 MIN READ
NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune | Glycotest Diagnostics